130 related articles for article (PubMed ID: 7615360)
1. Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer.
Sauter G; Moch H; Carroll P; Kerschmann R; Mihatsch MJ; Waldman FM
Int J Cancer; 1995 Apr; 64(2):99-103. PubMed ID: 7615360
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization.
Stadler WM; Steinberg G; Yang X; Hagos F; Turner C; Olopade OI
Clin Cancer Res; 2001 Jun; 7(6):1676-82. PubMed ID: 11410506
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.
Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R
Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867
[TBL] [Abstract][Full Text] [Related]
4. Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma.
Hopman AH; Kamps MA; Speel EJ; Schapers RF; Sauter G; Ramaekers FC
Am J Pathol; 2002 Oct; 161(4):1119-25. PubMed ID: 12368185
[TBL] [Abstract][Full Text] [Related]
5. Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization.
Sauter G; Deng G; Moch H; Kerschmann R; Matsumura K; De Vries S; George T; Fuentes J; Carroll P; Mihatsch MJ
Am J Pathol; 1994 Apr; 144(4):756-66. PubMed ID: 8160775
[TBL] [Abstract][Full Text] [Related]
6. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.
Balázs M; Carroll P; Kerschmann R; Sauter G; Waldman FM
Genes Chromosomes Cancer; 1997 Jun; 19(2):84-9. PubMed ID: 9171998
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.
Hartmann A; Schlake G; Zaak D; Hungerhuber E; Hofstetter A; Hofstaedter F; Knuechel R
Cancer Res; 2002 Feb; 62(3):809-18. PubMed ID: 11830537
[TBL] [Abstract][Full Text] [Related]
8. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
[TBL] [Abstract][Full Text] [Related]
9. Y chromosome loss detected by FISH in bladder cancer.
Sauter G; Moch H; Wagner U; Novotna H; Gasser TC; Mattarelli G; Mihatsch MJ; Waldman FM
Cancer Genet Cytogenet; 1995 Jul; 82(2):163-9. PubMed ID: 7664248
[TBL] [Abstract][Full Text] [Related]
10. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
[TBL] [Abstract][Full Text] [Related]
11. c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization.
Sauter G; Carroll P; Moch H; Kallioniemi A; Kerschmann R; Narayan P; Mihatsch MJ; Waldman FM
Am J Pathol; 1995 May; 146(5):1131-9. PubMed ID: 7747807
[TBL] [Abstract][Full Text] [Related]
12. Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: a FISH study.
Placer J; Espinet B; Salido M; Solé F; Gelabert-Mas A
Urology; 2005 May; 65(5):913-8. PubMed ID: 15882723
[TBL] [Abstract][Full Text] [Related]
13. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive detection of alterations in chromosome numbers in urinary bladder cancer cells, using fluorescence in situ hybridization.
Okamura T; Umemoto Y; Yasui T; Saiki S; Kuroda H; Kotoh S; Kamizaki H
Int J Clin Oncol; 2004 Oct; 9(5):373-7. PubMed ID: 15549587
[TBL] [Abstract][Full Text] [Related]
16. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
17. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer.
Shao L; Lerner SL; Bondaruk J; Czerniak BA; Zeng X; Grossman HB; Spitz MR; Wu X
Genes Chromosomes Cancer; 2004 Dec; 41(4):379-89. PubMed ID: 15390184
[TBL] [Abstract][Full Text] [Related]
18. Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?
Bartlett JM; Watters AD; Ballantyne SA; Going JJ; Grigor KM; Cooke TG
Br J Cancer; 1998 Jun; 77(12):2193-8. PubMed ID: 9649132
[TBL] [Abstract][Full Text] [Related]
19. [Ki-67 fraction, p53 alteration and numerical chromosome aberrations (chromosomes 7 and 17) in formalin fixed bladder tumors].
Moch H; Sauter G; Gudat F; Waldman F; Mihatsch MJ
Verh Dtsch Ges Pathol; 1993; 77():226-30. PubMed ID: 7511286
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines.
Williams SV; Sibley KD; Davies AM; Nishiyama H; Hornigold N; Coulter J; Kennedy WJ; Skilleter A; Habuchi T; Knowles MA
Genes Chromosomes Cancer; 2002 May; 34(1):86-96. PubMed ID: 11921286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
